Search by Drug Name or NDC
NDC 51655-0765-21 Prednisone 5 mg/1 Details
Prednisone 5 mg/1
Prednisone is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Northwind Pharmaceuticals. The primary component is PREDNISONE.
MedlinePlus Drug Summary
Prednisone is used alone or with other medications to treat the symptoms of low corticosteroid levels (lack of certain substances that are usually produced by the body and are needed for normal body functioning). Prednisone is also used to treat other conditions in patients with normal corticosteroid levels. These conditions include certain types of arthritis; severe allergic reactions; multiple sclerosis (a disease in which the nerves do not function properly); lupus (a disease in which the body attacks many of its own organs); and certain conditions that affect the lungs, skin, eyes, kidneys blood, thyroid, stomach, and intestines. Prednisone is also sometimes used to treat the symptoms of certain types of cancer. Prednisone is in a class of medications called corticosteroids. It works to treat patients with low levels of corticosteroids by replacing steroids that are normally produced naturally by the body. It works to treat other conditions by reducing swelling and redness and by changing the way the immune system works.
Related Packages: 51655-0765-21Last Updated: 04/21/2024
MedLinePlus Full Drug Details: Prednisone
Product Information
| NDC | 51655-0765 |
|---|---|
| Product ID | 51655-765_da7f948f-803a-5f0d-e053-2a95a90ad0f0 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Prednisone |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Prednisone |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/1 |
| Substance Name | PREDNISONE |
| Labeler Name | Northwind Pharmaceuticals |
| Pharmaceutical Class | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA080292 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 51655-0765-21 (51655076521)
| NDC Package Code | 51655-765-21 |
|---|---|
| Billing NDC | 51655076521 |
| Package | 21 TABLET in 1 BOTTLE, PLASTIC (51655-765-21) |
| Marketing Start Date | 2021-07-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |